Leveraging Endocrine and Metabolic Vulnerabilities in ER+ Breast Cancer
Image

When
12:10 p.m., March 31, 2023
“Leveraging Endocrine and Metabolic Vulnerabilities in ER+ Breast Cancer”
Todd W. Miller, PhD
Associate Professor of Molecular and Systems Biology
Dartmouth Geisel School of Medicine